Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorSchnabel, Annegret-
dc.creatorBlois, Sandra M.-
dc.creatorMeint, Peter-
dc.creatorFreitag, Nancy-
dc.creatorErnst, Wolfgang-
dc.creatorBarrientos, Gabriela Laura-
dc.creatorConrad, Melanie L.-
dc.creatorRose, Matthias-
dc.creatorSeelbach-Göbel, Birgit-
dc.date2018-05-03T17:08:51Z-
dc.date2018-05-03T17:08:51Z-
dc.date2016-04-
dc.date2018-05-03T13:57:04Z-
dc.date.accessioned2019-04-29T15:26:15Z-
dc.date.available2019-04-29T15:26:15Z-
dc.date.issued2016-04-
dc.identifierSchnabel, Annegret; Blois, Sandra M.; Meint, Peter; Freitag, Nancy; Ernst, Wolfgang; et al.; Elevated systemic galectin-1 levels characterize HELLP syndrome.; Elsevier Ireland; Journal of Reproductive Immunology; 114; 4-2016; 38-43-
dc.identifier0165-0378-
dc.identifierhttp://hdl.handle.net/11336/43966-
dc.identifierCONICET Digital-
dc.identifierCONICET-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/294163-
dc.descriptionGalectin-1 (gal-1), a member of a family of conserved β-galactoside-binding proteins, has been shown to exert a key role during gestation. Though gal-1 is expressed at higher levels in the placenta from HELLP patients, it is still poorly understood whether systemic gal-1 levels also differ in HELLP patients. In the present study, we evaluated the systemic expression of gal-1, together with the angiogenic factors, placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) in conjunction with HELLP syndrome severity. Systemic levels of gal-1 and sFlt-1 were elevated in patients with both early- and late-onset HELLP syndrome as compared to healthy controls. In contrast, peripheral PlGF levels were decreased in early- and late-onset HELLP. A positive correlation between systemic gal-1 levels and sFlt-1/PlGF ratios was found in early onset HELLP patients. Our results show that HELLP syndrome is associated with increased circulating levels of gal-1; integrating systemic gal-1 measurements into the diagnostic analyses of pregnant women may provide more effective prediction of HELLP syndrome development-
dc.descriptionFil: Schnabel, Annegret. Universitat Regensburg; Alemania-
dc.descriptionFil: Blois, Sandra M.. Charité-Universitätsmedizin Berlin; Alemania-
dc.descriptionFil: Meint, Peter. Universitat Regensburg; Alemania-
dc.descriptionFil: Freitag, Nancy. Charité-Universitätsmedizin Berlin; Alemania-
dc.descriptionFil: Ernst, Wolfgang. Universitat Regensburg; Alemania-
dc.descriptionFil: Barrientos, Gabriela Laura. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Charité-Universitätsmedizin Berlin; Alemania-
dc.descriptionFil: Conrad, Melanie L.. Charité-Universitätsmedizin Berlin; Alemania-
dc.descriptionFil: Rose, Matthias. Charité-Universitätsmedizin Berlin; Alemania-
dc.descriptionFil: Seelbach-Göbel, Birgit. Universitat Regensburg; Alemania-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherElsevier Ireland-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jri.2016.02.002-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0165037815300735-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.subjectANGIOGENIC FACTORS-
dc.subjectGALECTIN-1-
dc.subjectHELLP-
dc.subjectPREGNANCY-
dc.subjectInmunología-
dc.subjectMedicina Básica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.subjectMedicina Critica y de Emergencia-
dc.subjectMedicina Clínica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleElevated systemic galectin-1 levels characterize HELLP syndrome.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.